Occlusion of gallbladder

Summary

Occlusion of gallbladder (MONDO:0004858) is a disease. A subtype of gallbladder disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	occlusion of gallbladder
Mondo ID	MONDO:0004858
DOID	DOID:9714
ICD-10-CM	K82.0
ICD-11	1945915335
SNOMED CT	197416005
UMLS	C0156214
MedGen	57845
Is cancer (heuristic)	no

Also known as: obstruction of gallbladder

Disease family

This is a subtype of gallbladder disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › hepatobiliary disorder › gallbladder disorder › occlusion of gallbladder

Related subtypes (10): cholesterolosis of gallbladder, cholecystitis, hydrops of gallbladder, biliary dyskinesia, cholecystolithiasis, gallbladder neoplasm, polyp of gallbladder, Rokitansky-Aschoff sinuses of the gallbladder, hereditary gallbladder disorder, gallbladder duplication

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.